Browsing: Longevity and Mortality Risk Trends

The outlook for metastatic melanoma continues to improve, driven by advancements in therapeutic strategies and ongoing research.

Life Risk News Q&A: Cobus Daneel, Chair, Continuous Mortality Investigation Projections Committee, shares what is top of mind in the mortality actuarial world as we look ahead to 2025.

New research suggests that the chances then that the next 100 years or so brings about a similar jump?

It could take decades for the new legislation to have any discernible impact on mortality.

While ageing is fundamentally a physiological phenomenon, numerous factors significantly influence the rate at which this process occurs. Certain factors can accelerate the ageing process, while some have the potential to decelerate it, influencing the rate of physiological decline.

US life expectancy gap to other developed countries has widened in the past two years.

New technological advances to meet key healthcare needs are a crucial element driving the performance profile of the healthcare sector.

New analysis from consulting firm LCP suggests the value of the €20-30bn of Dutch pension fund liabilities expected to be bought out by insurers by 2027 could differ by at least €500m depending on the model used.

Industry leaders speaking at the Secondary Life Markets Conference 2024 paint a picture of optimism as the year enters the home stretch.

A new report from Swiss Re suggests that excess mortality may continue to remain higher then pre-pandemic levels unless action is taken.